Cosmos Health Inc. (COSM) stock
Close on Nov 12, 2026Market cap $20.89MP/E –Yield –
Cosmos Health Inc. grew revenue 33.8% to $73.73M over the twelve months to Jun 30, 2026. Free cash flow was -$9.93M. At the latest close the market valued the company at $20.89M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $20.89M
- P/E ratio
- –
- Price to sales
- 0.28
- Price to book
- 1.01
- Dividend yield
- –
- Free cash flow yield
- -47.54%
Fundamentals
- Revenue
- $73.73M
- Net income
- -$24.39M
- EPS, diluted
- -$0.61
- Free cash flow
- -$9.93M
- Book value per share
- $0.35
- Diluted shares
- 60M
Trading
- Previous close
- $0.24
- Open
- $0.22
- Day's range
- $0.20 – $0.23
- Volume
- 2,575,926
- Average volume (20 days)
- 2,333,938
- 52-week range
- $0.16 – $0.77
- RSI (14 days)
- 38.4
- Volatility (1 year)
- 104.2%
- Relative volume
- 0.68×
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | COSM | S&P 500 | Difference | COSM per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -40.6% | -2.7% | −37.9 pts | ||
| 3 months | +0.2% | -1.7% | +2.0 pts | ||
| Year to date | -58.3% | +11.9% | −70.2 pts | ||
| 1 year | -71.6% | +12.0% | −83.6 pts | ||
| 3 years | -80.2% | +78.2% | −158.4 pts | -41.7% | +21.2% |
| 5 years | -94.5% | +73.2% | −167.7 pts | -43.9% | +11.6% |
| 10 years | -96.4% | +309.6% | −406.0 pts | -28.2% | +15.1% |
Fifteen years at a glance
Fiscal years 2010 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Cosmos Health filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Update
- Results
About Cosmos Health
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Cosmos Health Inc. is a vertically integrated healthcare company that develops, manufactures, and distributes generic pharmaceuticals, proprietary nutraceuticals, biocides, and other healthcare products. The company also operates a direct-to-consumer telehealth platform and conducts research and development focused on novel oncology therapies, weight management solutions, and AI-driven drug repurposing. Its offerings encompass prescription and over-the-counter medications, antiseptic soaps, and dietary supplements, as well as contract manufacturing organization services. The group's customer base includes retail pharmacies, wholesale drug distributors, hospitals, and clinics, along with individual consumers using its virtual care services.
Company profile, executives and historyCosmos Health stock: common questions
What is Cosmos Health's stock price?
COSM closed at $0.21 on Nov 12, 2026, down 12.07% on the day. Over the past 52 weeks it traded between $0.16 and $0.77.
What is Cosmos Health's market cap?
Cosmos Health was worth $20.89M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is COSM's P/E ratio?
Cosmos Health lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.61), so it has no meaningful P/E ratio.
How much revenue does Cosmos Health make?
Cosmos Health reported revenue of $73.73M for the twelve months to Jun 30, 2026, up 33.8% from a year earlier.
Does Cosmos Health pay a dividend?
No. Cosmos Health has not paid a cash dividend over the last twelve months.
How has COSM stock performed over the past year?
Including dividends, COSM returned -71.6% over the past year, against +12.0% for the S&P 500.
How many COSM shares are sold short?
2M shares were sold short at the latest FINRA report, 2.13% of the float, or 1.0 days of average trading volume.
Who are Cosmos Health's competitors?
Companies most similar to Cosmos Health by business, industry and size include MEDS, HKPD, NUS, HYFM, PRE.
See a number that looks wrong?